AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

RUA LIFE SCIENCES PLC

AGM Information Aug 28, 2024

7892_dva_2024-08-28_ebcd2221-c82b-49cc-bdc9-9f5324e8ee41.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8926B

RUA Life Sciences PLC

28 August 2024

28 August 2024

RUA Life Sciences plc

("RUA" the "Company" or the "Group")

Result of AGM

RUA Life Sciences plc (AIM:RUA.L), the holding company of a group of medical device businesses focussed on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon ™), announces that all resolutions put forward to its Annual General Meeting held yesterday were duly passed and the votes cast were as follows:

Res No. Votes For % Votes Against % Votes Withheld
01 6,051,300 99.37% 38,570 0.63% 0
02 6,050,279 99.36% 38,783 0.64% 808
03 6,051,300 99.37% 38,570 0.63% 0
04 6,045,927 99.28% 43,943 0.72% 0
05 6,045,698 99.27% 44,172 0.73% 0
06 5,941,757 97.57% 148,113 2.43% 0
07 5,941,757 97.57% 148,113 2.43% 0

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website ( www.rualifesciences.com ).

For further information contact:

RUA Life Sciences Tel: +44 (0)1294 317073
Bill Brown, CEO
Lachlan Smith, CFO
Cavendish Capital Markets Limited
(Nominated Adviser and Broker) Tel: +44 (0)20 7220 0500
Giles Balleny/Dan Hodkinson (Corporate Finance)
Charlie Combe (Broking)
Michael Johnson (Sales)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

RAGPRMPTMTTTBAI

Talk to a Data Expert

Have a question? We'll get back to you promptly.